Joachim Moecks

800 total citations
16 papers, 485 citations indexed

About

Joachim Moecks is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Joachim Moecks has authored 16 papers receiving a total of 485 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 8 papers in Oncology and 3 papers in Surgery. Recurrent topics in Joachim Moecks's work include Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Research Studies (5 papers) and Colorectal Cancer Treatments and Studies (4 papers). Joachim Moecks is often cited by papers focused on Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Research Studies (5 papers) and Colorectal Cancer Treatments and Studies (4 papers). Joachim Moecks collaborates with scholars based in Germany, Switzerland and United States. Joachim Moecks's co-authors include Quynh Anh Lu, Frank H. Wians, John A. Todd, Alan H.B. Wu, Tony Mok, Luis Paz‐Ares, Denis Soulières, Barbara Klughammer, Rafael Rosell and I. Melezínek and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Clinical Chemistry.

In The Last Decade

Joachim Moecks

15 papers receiving 468 citations

Peers

Countries citing papers authored by Joachim Moecks

Since Specialization

Citations

This map shows the geographic impact of Joachim Moecks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joachim Moecks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joachim Moecks more than expected).

Fields of papers citing papers by Joachim Moecks

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joachim Moecks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joachim Moecks. The network helps show where Joachim Moecks may publish in the future.

Co-authorship network of co-authors of Joachim Moecks

This figure shows the co-authorship network connecting the top 25 collaborators of Joachim Moecks. A scholar is included among the top collaborators of Joachim Moecks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joachim Moecks. Joachim Moecks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Top-level MET gene copy number gain defines a subtype of poorly differentiated pulmonary adenocarcinomas with poor prognosis 2020 ·Translational Lung Cancer Research ·Tobias R. Overbeck, (unknown), Katja Schmitz, Achim Rittmeyer, (unknown), (unknown), (unknown), (unknown), (unknown), Marc Hinterthaner, Kirsten Reuter‐Jessen, (unknown), Joachim Moecks, Annalen Bleckmann, Hans‐Ulrich Schildhaus	21
2	Impact of a digital platform (PDMone) on glycemic control as support of the specialist diabetes care 2019 ·Diabetologie und Stoffwechsel ·Andreas Reichel, Joachim Moecks, (unknown), Bernhard Kulzer, (unknown)	0
3	ReadMax—a novel reading and scoring approach for EGFR gene copy number to predict therapeutic benefit of erlotinib treatment in EGFR wild‐type non‐small‐cell lung cancer 2015 ·The Journal of Pathology Clinical Research ·Joachim Moecks, Denis Soulières, Barbara Klughammer	2
4	Pooled analysis of clinical outcome for EGFR TKI‐treated patients with EGFR mutation‐positive NSCLC 2014 ·Journal of Cellular and Molecular Medicine ·Luis Paz‐Ares, Denis Soulières, Joachim Moecks, Ilze Bāra, Tony Mok, Barbara Klughammer	31
5	Pooled Analysis of Clinical Outcomes for Patients with EGFR Mutations in Non-Small-Cell Lung Cancer: An Update 2012 ·Annals of Oncology ·Luis Paz‐Ares, Denis Soulières, Barbara Klughammer, Ilze Bāra, Joachim Moecks, Tony Mok	3
6	Clinical outcomes in non‐small‐cell lung cancer patients with EGFR mutations: pooled analysis 2010 ·Journal of Cellular and Molecular Medicine ·Luis Paz‐Ares, Denis Soulières, I. Melezínek, Joachim Moecks, (unknown), Tony Mok, Rafael Rosell, Barbara Klughammer	112
7	Short- and Long-Term Biological Variation in Cardiac Troponin I Measured with a High-Sensitivity Assay: Implications for Clinical Practice 2008 ·Clinical Chemistry ·Alan H.B. Wu, Quynh Anh Lu, John A. Todd, Joachim Moecks, Frank H. Wians	192
8	N-Terminal Pro–B-Type Natriuretic Peptide Concentrations Predict the Risk of Cardiovascular Adverse Events from Antiinflammatory Drugs: A Pilot Trial 2008 ·Clinical Chemistry ·Kay Brune, Hugo A. Katus, Joachim Moecks, Eberhard Spanuth, Allan S. Jaffe, Evangelos Giannitsis	11
9	Association between different potential predictive markers from TRUST, a trial of erlotinib in non-small cell lung cancer (NSCLC) 2007 ·Journal of Clinical Oncology ·Eckart Laack, (unknown), Thorsten Gutjahr, Ernst Heinmöller, Veronika Lutz, Joachim Moecks, (unknown), (unknown), Olivia Spleiss, Martin Reck	5
10	N-Terminal-proBNP (NT-proBNP) as an indicator of cardiac dysfunction 2005 ·Zeitschrift für Kardiologie ·(unknown), Joachim Moecks, Dietmar Zdunek	17
11	Exploratory analyses EGFR, kRAS mutations and other molecular markers in tumors of NSCLC patients (pts) treated with chemotherapy +/- erlotinib (TALENT) 2005 ·Journal of Clinical Oncology ·U. Gatzemeier, (unknown), Dorothee Foernzler, Joachim Moecks, (unknown), Francesca Rosa, Guido Sauter, U. Brennscheidt	39
12	PD-155 Molecular markers such as EGFR and kRAS mutations aspredictors of sensitivity to erlotinib in patients (pts) with NSCLC: Exploratory subanalyses of TALENT, a phase III trial 2005 ·Lung Cancer ·Martin Reck, (unknown), Dorothee Foernzler, Joachim Moecks, (unknown), Francesca Rosa, Guido Sauter, U. Brennscheidt, U. Gatzemeier	2
13	Classification of signatures of Bovine Spongiform Encephalopathy in serum using infrared spectroscopy 2004 ·The Analyst ·(unknown), Joachim Moecks, (unknown), Saira Cawthraw, B. Dolenko, Michael Eiden, (unknown), W. Köhler, Jürgen Schmitt, Ray Somorjai, Thomas Udelhoven, S. Verzakov, Wolfgang Petrich	31
14	Measures of Morbidity in Clinical Studies with Recurrent Skeletal Complications 2004 ·Journal of Biopharmaceutical Statistics ·Joachim Moecks, Gary G. Koch, Martin Scott, M. Budde, (unknown), W Koehler, (unknown)	3
15	Progress in diagnostic pattern recognition (DPR) 2004 ·Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE ·Joachim Moecks, (unknown), (unknown), Wolfgang Petrich	4
16	Improvement of bone pain, quality of life and survival time of breast cancer patients with metastatic bone disease treated with intravenous ibandronate 1999 ·European Journal of Cancer ·Ingo Diel, М. Р. Личиницер, J.J. Body, (unknown), Joachim Moecks, F. Cavalli, W. Dornoff, Vera Gorbunova, Eugène McCloskey, (unknown), John А. Kanis	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact